Red Light Holland Corp (TSE:TRIP) has released an update.
Red Light Holland Corp. has initiated a research project to develop a commercial manufacturing process for natural-source Psilocybin Active Pharmaceutical Ingredient (API) from its psilocybin truffles. This move is in response to growing market demand for medical products derived from psilocybin, with the potential to produce high-margin medical products and valuable intellectual property. The project, in collaboration with PharmAla Biotech, aims to create a standardized extraction and purification process to enable GMP manufacturing in various countries.
For further insights into TSE:TRIP stock, check out TipRanks’ Stock Analysis page.
